Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event

business newsImage via Pixabay

PHILADELPHIA, PA — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) and GRI Bio, Inc. announced that David Baker, President & Chief Executive Officer of Vallon and Marc Hertz, Chief Executive Officer of GRI Bio, will present at the Virtual Investor 2023 Companies to Watch Event on Tuesday, January 17, 2023, at 1:00 PM ET.

As part of the presentation, Vallon and GRI Bio will discuss their previously announced definitive agreement (the “Merger Agreement”) pursuant to which GRI Bio will merge with a wholly-owned subsidiary of Vallon in an all-stock transaction (the “Merger”). The combined company will focus on advancing GRI Bio’s innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases. The transaction is expected to close in the first quarter of 2023.

A live video webcast of the presentation will be available on the Events pages of the Investors section of the Company’s website (www.vallon-pharma.com).

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.

READ:  SliCE Debuts Football and Heart Shaped Pizzas for Super Bowl and Valentine's Season